MMWR for Use of Meningococcal Conjugate Vaccines in HIV-Infected “Recommendation Persons”, Advisory Committee on Immunization Practices (ACIP) (November 4, 2016) VFC Resolution 10/16-3, Vaccines to Prevent Meningococcal Disease – http;//www.cdc.gov/vaccines/programs/vfc/downloads/resolutions/2016-10-3-mening.pdf Immunization Action Coalition (IAC), Meningococcal Vaccine Recommendations by Age and Risk Factor for Serogroups A, C, W, or Y Protection (12/16) http://www.immunize.org/catg.d/p2018.pdf MMWR and Control of Meningococcal Disease: Recommendations of the Advisory “Prevention Committee on Immunization Practices (ACIP) (March 22, 2013) Footnotes to the Immunization Schedule for Children and Adolescents Aged “Recommended 18 or Younger, UNITED STATES, 2017”: Footnotes to the Immunization Schedule for Adults Aged 19 Years or Older, “Recommended United States, 2017”: VFC Resolution 10/2013 Meningococcal – MENVEO Package Insert (revised 10/2016): Updated March 31, 2013, July 1, 2014, and July1, 2017
MMWR “Recommendation for Use of Meningococcal Conjugate Vaccines in HIV-Infected Persons”, Advisory Committee on Immunization Practices (ACIP) (November 4, 2016) VFC Resolution – 10/16-3, Vaccines to Prevent Meningococcal Disease http;//www.cdc.gov/vaccines/programs/vfc/downloads/resolutions/2016-10-3-mening.pdf Immunization Action Coalition (IAC), Meningococcal Vaccine Recommendations by Age and Risk Factor for Serogroups A, C, W, or Y Protection (12/16) http://www.immunize.org/catg.d/p2018.pdf MMWR “Prevention and Control of Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP) (March 22, 2013) Footnotes to the “Recommended Immunization Schedule for Children and Adolescents Aged 18 or Younger, UNITED STATES, 2017”: Footnotes to the “Recommended Immunization Schedule for Adults Aged 19 Years or Older, United States, 2017”: VFC Resolution – 10/2013 Meningococcal MENVEO Package Insert (revised 10/2016): Updated March 31, 2013, July 1, 2014, and July1, 2017